{"doi":"10.1371/journal.pone.0272364","title":"A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike","abstract":"Neutralizing antibodies targeting the SARS-CoV-2 spike protein have shown a great preventative/therapeutic potential. Here, we report a rapid and efficient strategy for the development and design of SARS-CoV-2 neutralizing humanized nanobody constructs with sub-nanomolar affinities and nanomolar potencies. CryoEM-based structural analysis of the nanobodies in complex with spike revealed two distinct binding modes. The most potent nanobody, RBD-1-2G(NCATS-BL8125), tolerates the N501Y RBD mutation and remains capable of neutralizing the B.1.1.7 (Alpha) variant. Molecular dynamics simulations provide a structural basis for understanding the neutralization process of nanobodies exclusively focused on the spike-ACE2 interface with and without the N501Y mutation on RBD. A primary human airway air-lung interface (ALI) ex vivo model showed that RBD-1-2G-Fc antibody treatment was effective at reducing viral burden following WA1 and B.1.1.7 SARS-CoV-2 infections. Therefore, this presented strategy will serve as a tool to mitigate the threat of emerging SARS-CoV-2 variants.","journal":"PLoS ONE","year":2022,"id":257737,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":18,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9563,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":637480,"name":"Juliana da Fonseca Rezende e Mello","orcid":null,"position":1,"is_corresponding":false},{"id":375868,"name":"Bryan D. Fleming","orcid":"0000-0003-3556-0852","position":2,"is_corresponding":false},{"id":267850,"name":"Alex Renn","orcid":"0000-0001-6320-9459","position":3,"is_corresponding":false},{"id":227988,"name":"Catherine Z. Chen","orcid":"0000-0002-6900-6553","position":4,"is_corresponding":false},{"id":267852,"name":"Xin Hu","orcid":"0000-0003-1164-5130","position":5,"is_corresponding":false},{"id":227989,"name":"Miao Xu","orcid":"0000-0001-9968-733X","position":6,"is_corresponding":false},{"id":249035,"name":"Kirill Gorshkov","orcid":"0000-0002-4652-8818","position":7,"is_corresponding":false},{"id":550314,"name":"Quinlin Hanson","orcid":"0000-0001-6033-8415","position":8,"is_corresponding":false},{"id":227992,"name":"Wei Zheng","orcid":"0000-0003-1034-0757","position":9,"is_corresponding":false},{"id":313660,"name":"Emily M. Lee","orcid":"0000-0001-8451-978X","position":10,"is_corresponding":false},{"id":52314,"name":"Lalith Perera","orcid":null,"position":11,"is_corresponding":false},{"id":605486,"name":"Robert M. Petrovich","orcid":"0009-0008-6229-0281","position":12,"is_corresponding":false},{"id":227990,"name":"Manisha Pradhan","orcid":"0000-0002-8710-0148","position":13,"is_corresponding":false},{"id":268257,"name":"Richard T. Eastman","orcid":"0000-0003-3580-380X","position":14,"is_corresponding":false},{"id":268258,"name":"Zina Itkin","orcid":"0000-0003-1686-1326","position":15,"is_corresponding":false},{"id":549767,"name":"Thomas B. Stanley","orcid":null,"position":16,"is_corresponding":false},{"id":227364,"name":"Allen L. Hsu","orcid":"0000-0003-2065-3802","position":17,"is_corresponding":false},{"id":258055,"name":"Venkata P. Dandey","orcid":"0000-0001-7283-2664","position":18,"is_corresponding":false},{"id":908235,"name":"Kedar Sharma","orcid":"0000-0002-6679-2341","position":19,"is_corresponding":false},{"id":267816,"name":"William Gillette","orcid":"0000-0002-8592-3642","position":20,"is_corresponding":false},{"id":267812,"name":"Troy Taylor","orcid":"0000-0001-6775-629X","position":21,"is_corresponding":false},{"id":823087,"name":"Nitya Ramakrishnan","orcid":null,"position":22,"is_corresponding":false},{"id":823088,"name":"Shelley Perkins","orcid":null,"position":23,"is_corresponding":false},{"id":267809,"name":"Dominic Esposito","orcid":"0000-0002-9987-1687","position":24,"is_corresponding":false},{"id":287616,"name":"Eunkeu Oh","orcid":"0000-0003-1641-522X","position":25,"is_corresponding":false},{"id":287617,"name":"Kimihiro Susumu","orcid":"0000-0003-4389-2574","position":26,"is_corresponding":false},{"id":287618,"name":"Mason A. Wolak","orcid":"0000-0001-5296-0378","position":27,"is_corresponding":false},{"id":228425,"name":"Marc Ferrer","orcid":"0000-0003-4569-9137","position":28,"is_corresponding":false},{"id":255126,"name":"Matthew D. Hall","orcid":"0000-0002-5073-442X","position":29,"is_corresponding":false},{"id":227365,"name":"Mario J. Borgnia","orcid":"0000-0001-9159-1413","position":30,"is_corresponding":false},{"id":228423,"name":"Anton Simeonov","orcid":"0000-0002-4523-9977","position":31,"is_corresponding":false},{"id":267851,"name":"Ying Fu","orcid":"0000-0002-3805-1028","position":0,"is_corresponding":true}],"reference_count":40,"raw_metadata":null,"created_at":"2026-07-19T00:25:34.440699Z","pmid":"35947606","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}